EICHOR
● Completed
Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females
Condition: Contraception · Change in Bone Mineral Density · Sponsor: Insud Pharma
About this study
This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The secondary objective of Part A is to evaluate the safety and tolerability of LPRI-CF113. The primary objective of Part B is to evaluate the impact of LPRI-CF113 on bone mineral density (BMD) at the lumbar spine (L1-L4) after 12 months (13 medication cycles). The secondary objective of Part B is to evaluate the impact of LPRI-CF113 on BMD and bone turnover after 12 months (13 medication cycles) at the femoral neck, total hip, and total body.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (47)
| Alabama Clinical Therapeutics, LLC | Alabaster, Alabama, United States | — |
| Alabama Clinical Therapeutics, LLC | Birmingham, Alabama, United States | — |
| Del Sol Research Management | Tucson, Arizona, United States | — |
| Eclipse Clinical Research | Tucson, Arizona, United States | — |
| Cornerstone Research Institute - Longwood | Altamonte Springs, Florida, United States | — |
| Encore Medical Research of Boynton Beach LLC. | Boynton Beach, Florida, United States | — |
| Women's Medical Research Group | Clearwater, Florida, United States | — |
| Direct Helpers Research Center | Hialeah, Florida, United States | — |
| Inpatient Research Clinic, LLC | Hialeah, Florida, United States | — |
| Vital Pharma Research, Inc. | Hialeah, Florida, United States | — |
| Encore Medical Research, LLC | Hollywood, Florida, United States | — |
| Global Research Associates | Homestead, Florida, United States | — |
+ 35 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05461573